Search

Search Constraints

You searched for: Author/Creator Visser, Denise

Search Results

1. [18F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers. (7th September 2021)

2. Early‐onset Alzheimer's disease is related to differential spatial patterns of tau pathology and cognitive impairment: Neuropsychology/Neuropsychological profiles of dementia: Valid biomarkers?. (7th December 2020)

3. IC‐P‐184: LONGITUDINAL DYNAMIC [18F]FLORTAUCIPIR PET REVEALS INCREASED EARLY STAGE TAU PATHOLOGY IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE. (1st July 2019)

4. IC‐P‐187: [18F]FLORTAUCIPIR BINDING STRONGLY CORRELATES TO COGNITION ACROSS THE CLINICAL ALZHEIMER'S DISEASE CONTINUUM, INDEPENDENTLY OF CSF TAU. (1st July 2019)

5. IC‐P‐222: [18F]AV1451 PET IN RELATION TO ATROPHY ACROSS THE ALZHEIMER'S DISEASE SPECTRUM. (1st July 2006)

6. Isocaloric low protein diet in a mouse model for vanishing white matter does not impact ISR deregulation in brain, but reveals ISR deregulation in liver. (3rd June 2022)

7. Longitudinal [18F]flortaucipir PET: Comparison of quantitative and semi‐quantitative parameters. (1st February 2022)

8. Longitudinal [18F]flortaucipir PET: Comparison of quantitative and semi‐quantitative parameters. (December 2021)

9. O5‐01‐03: EARLY TAU PET PATHOLOGY IS ASSOCIATED WITH MEMORY PERFORMANCE IN COGNITIVELY UNIMPAIRED INDIVIDUALS WITH SCD: THE SCIENCE PROJECT. (1st July 2019)

10. P1‐412: [18F]FLORTAUCIPIR BINDING STRONGLY CORRELATES TO COGNITION ACROSS THE CLINICAL ALZHEIMER'S DISEASE CONTINUUM, INDEPENDENTLY OF CSF TAU. (1st July 2019)